Is FDA taking action on CBD products ‘for human consumption’?

An unconfirmed seizure of products from a shop in Arizona could be the first instance of enforcement on CBD by Food and Drug Administration (FDA) officials since the passage of the US 2018 Farm Bill.
A number of CBD-containing products were seized from a retail outlet in Yuma, according to local press reports. The action appears to have been undertaken by FDA agents supported by officers from another unidentified agency.
The shop, Neverlow Glass Gallery, said eight chocolate bars, 14 packs of gummies, and 23 K-cups (pods of coffee for a Nespresso or Keurig-style coffee machine) were taken by officials who had visited a week earlier and asked about CBD products for human consumption.

Read full article
I'm already a subscriber

Freddie Dawson

Senior news editor
Freddie studied at King’s College, London and City University and worked for publications including The Times, The Malay Mail, PathfinderBuzz and Solar Summary before joining the ECigIntelligence team. He has extensive experience in covering fast-moving consumer goods (FMCG), manufacturing and technological innovation.

Our Key Benefits

The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization